O-009 NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate

Abstract

Open access

Peer reviewed

J. Strosberg, E. Wolin, B. Chasen, M. Kulke, D. Bushnell, M. Chaplin, R. Baum, P. Kunz, T. Hobday, K. Oberg, …

Annals of oncology, Vol.27, p.ii121

06/2016

DOI: 10.1093/annonc/mdw198.09

Files and links (1)

url

https://doi.org/10.1093/annonc/mdw198.09View

Published (Version of record) Open Access

Title: Subtitle: O-009 NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate
Creators: J. Strosberg - Moffitt Cancer Center
E. Wolin - Cedars-Sinai Medical Center
B. Chasen - Markey Cancer Center
M. Kulke - Dana-Farber Cancer Institute
D. Bushnell - University of Iowa
M. Chaplin - The Royal Free Hospital
R. Baum - Zentralklinik Bad Berka
P. Kunz - Stanford University
T. Hobday - Mayo Clinic
K. Oberg - Uppsala University Hospital
M. Lopera Sierra
D. Kwekkeboom - Erasmus MC
P. Ruszniewski - Hôpital Beaujon
E. Krenning - Erasmus MC
A. Hendifar - Cedars-Sinai Medical Center
Resource Type: Abstract
Publication Details: Annals of oncology, Vol.27, p.ii121
DOI: 10.1093/annonc/mdw198.09
ISSN: 0923-7534
eISSN: 1569-8041
Language: English
Date published: 06/2016
Academic Unit: Radiology
Record Identifier: 9984320093602771

28 Record Views